Skip to main content

ICD-10-PCS FY2025 code changes

Historical release · ICD-10-PCS FY2025 · Effective October 1, 2024 – March 31, 2025 ICD-10-PCS FY2027 is the release in force (effective October 1, 2026).

Part of FY2025 coding changes

Every recorded ICD-10-PCS code addition, deletion, description revision, billable-status change and tabular-instruction change for FY2025, effective October 1, 2024.

These changes are based on recorded release data. MedCoder does not generate coding changes with AI.

Release
ICD-10-PCS FY2025
Effective
October 1, 2024
Code set period
2024-10-01 through 2025-03-31

FY2025 at a glance

371Added371 of them valid for submission61Deleted61 were valid for submission

Explore the complete recorded change list →

Compare a code

Enter any ICD-10-PCS code to see what this release does to it: added, deleted, description revised, billable status changed, new child codes, or no change at all. The answer is a lookup against the recorded changes below — nothing is generated.

Deleted codes — what to report instead

These codes leave the code set on October 1, 2024. Where a successor was determined from the source files it is named below; where none was, that is stated rather than guessed.

No successor was determined for these codes.

FY2024 (April) codeFY2024 (April) descriptionFY2025 statusEffective
X27H385Dilation of Right Femoral Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27H395Dilation of Right Femoral Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27H3B5Dilation of Right Femoral Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27H3C5Dilation of Right Femoral Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27J385Dilation of Left Femoral Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27J395Dilation of Left Femoral Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27J3B5Dilation of Left Femoral Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27J3C5Dilation of Left Femoral Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27K385Dilation of Proximal Right Popliteal Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27K395Dilation of Proximal Right Popliteal Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27K3B5Dilation of Proximal Right Popliteal Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27K3C5Dilation of Proximal Right Popliteal Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27L385Dilation of Proximal Left Popliteal Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27L395Dilation of Proximal Left Popliteal Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27L3B5Dilation of Proximal Left Popliteal Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27L3C5Dilation of Proximal Left Popliteal Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27M385Dilation of Distal Right Popliteal Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27M395Dilation of Distal Right Popliteal Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27M3B5Dilation of Distal Right Popliteal Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27M3C5Dilation of Distal Right Popliteal Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27N385Dilation of Distal Left Popliteal Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27N395Dilation of Distal Left Popliteal Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27N3B5Dilation of Distal Left Popliteal Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27N3C5Dilation of Distal Left Popliteal Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27P385Dilation of Right Anterior Tibial Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27P395Dilation of Right Anterior Tibial Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27P3B5Dilation of Right Anterior Tibial Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27P3C5Dilation of Right Anterior Tibial Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27Q385Dilation of Left Anterior Tibial Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27Q395Dilation of Left Anterior Tibial Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27Q3B5Dilation of Left Anterior Tibial Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27Q3C5Dilation of Left Anterior Tibial Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27R385Dilation of Right Posterior Tibial Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27R395Dilation of Right Posterior Tibial Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27R3B5Dilation of Right Posterior Tibial Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27R3C5Dilation of Right Posterior Tibial Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27S385Dilation of Left Posterior Tibial Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27S395Dilation of Left Posterior Tibial Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27S3B5Dilation of Left Posterior Tibial Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27S3C5Dilation of Left Posterior Tibial Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27T385Dilation of Right Peroneal Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27T395Dilation of Right Peroneal Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27T3B5Dilation of Right Peroneal Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27T3C5Dilation of Right Peroneal Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27U385Dilation of Left Peroneal Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27U395Dilation of Left Peroneal Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27U3B5Dilation of Left Peroneal Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
X27U3C5Dilation of Left Peroneal Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
XW033K5Introduction of Fosfomycin Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
XW033N5Introduction of Meropenem-vaborbactam Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
XW033U5Introduction of Imipenem-cilastatin-relebactam Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
XW043K5Introduction of Fosfomycin Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
XW043N5Introduction of Meropenem-vaborbactam Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
XW043U5Introduction of Imipenem-cilastatin-relebactam Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
XW097M5Introduction of Esketamine Hydrochloride into Nose, Via Natural or Artificial Opening, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
XW0DXJ5Introduction of Apalutamide Antineoplastic into Mouth and Pharynx, External Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
XW0DXL5Introduction of Erdafitinib Antineoplastic into Mouth and Pharynx, External Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
XW0DXR5Introduction of Venetoclax Antineoplastic into Mouth and Pharynx, External Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
XW0DXT5Introduction of Ruxolitinib into Mouth and Pharynx, External Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
XW0DXV5Introduction of Gilteritinib Antineoplastic into Mouth and Pharynx, External Approach, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024
XXE5XM5Measurement of Infection, Whole Blood Nucleic Acid-base Microbial Detection, New Technology Group 5Deleted — not valid for submissionOctober 1, 2024

The full recorded change list

Every recorded change, grouped by what kind of change it is. Each entry shows the code's own description first; tabular instructions and relationship text are labeled separately beneath it.

Added to the code set (371)

  • 00503Z4 — Destruction of Brain using Stereoelectroencephalographic Radiofrequency Ablation, Percutaneous Approach
  • 00K0XZ1 — Map Brain using Connectomic Analysis, External Approach
  • 041309R — Bypass Hepatic Artery to Lower Artery with Autologous Venous Tissue, Open Approach
  • 04130AR — Bypass Hepatic Artery to Lower Artery with Autologous Arterial Tissue, Open Approach
  • 04130JR — Bypass Hepatic Artery to Lower Artery with Synthetic Substitute, Open Approach
  • 04130KR — Bypass Hepatic Artery to Lower Artery with Nonautologous Tissue Substitute, Open Approach
  • 04130ZR — Bypass Hepatic Artery to Lower Artery, Open Approach
  • 041349R — Bypass Hepatic Artery to Lower Artery with Autologous Venous Tissue, Percutaneous Endoscopic Approach
  • 04134AR — Bypass Hepatic Artery to Lower Artery with Autologous Arterial Tissue, Percutaneous Endoscopic Approach
  • 04134JR — Bypass Hepatic Artery to Lower Artery with Synthetic Substitute, Percutaneous Endoscopic Approach
  • 04134KR — Bypass Hepatic Artery to Lower Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
  • 04134ZR — Bypass Hepatic Artery to Lower Artery, Percutaneous Endoscopic Approach
  • 041409R — Bypass Splenic Artery to Lower Artery with Autologous Venous Tissue, Open Approach
  • 04140AR — Bypass Splenic Artery to Lower Artery with Autologous Arterial Tissue, Open Approach
  • 04140JR — Bypass Splenic Artery to Lower Artery with Synthetic Substitute, Open Approach
  • 04140KR — Bypass Splenic Artery to Lower Artery with Nonautologous Tissue Substitute, Open Approach
  • 04140ZR — Bypass Splenic Artery to Lower Artery, Open Approach
  • 041449R — Bypass Splenic Artery to Lower Artery with Autologous Venous Tissue, Percutaneous Endoscopic Approach
  • 04144AR — Bypass Splenic Artery to Lower Artery with Autologous Arterial Tissue, Percutaneous Endoscopic Approach
  • 04144JR — Bypass Splenic Artery to Lower Artery with Synthetic Substitute, Percutaneous Endoscopic Approach
  • 04144KR — Bypass Splenic Artery to Lower Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
  • 04144ZR — Bypass Splenic Artery to Lower Artery, Percutaneous Endoscopic Approach
  • 047K342 — Dilation of Right Femoral Artery with Drug-eluting Intraluminal Device, Sustained Release, Percutaneous Approach
  • 047K352 — Dilation of Right Femoral Artery with Two Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
  • 047K362 — Dilation of Right Femoral Artery with Three Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
  • 047K372 — Dilation of Right Femoral Artery with Four or More Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
  • 047L342 — Dilation of Left Femoral Artery with Drug-eluting Intraluminal Device, Sustained Release, Percutaneous Approach
  • 047L352 — Dilation of Left Femoral Artery with Two Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
  • 047L362 — Dilation of Left Femoral Artery with Three Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
  • 047L372 — Dilation of Left Femoral Artery with Four or More Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
  • 047M342 — Dilation of Right Popliteal Artery with Drug-eluting Intraluminal Device, Sustained Release, Percutaneous Approach
  • 047M352 — Dilation of Right Popliteal Artery with Two Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
  • 047M362 — Dilation of Right Popliteal Artery with Three Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
  • 047M372 — Dilation of Right Popliteal Artery with Four or More Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
  • 047N342 — Dilation of Left Popliteal Artery with Drug-eluting Intraluminal Device, Sustained Release, Percutaneous Approach
  • 047N352 — Dilation of Left Popliteal Artery with Two Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
  • 047N362 — Dilation of Left Popliteal Artery with Three Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
  • 047N372 — Dilation of Left Popliteal Artery with Four or More Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
  • 047P342 — Dilation of Right Anterior Tibial Artery with Drug-eluting Intraluminal Device, Sustained Release, Percutaneous Approach
  • 047P352 — Dilation of Right Anterior Tibial Artery with Two Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
  • 047P362 — Dilation of Right Anterior Tibial Artery with Three Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
  • 047P372 — Dilation of Right Anterior Tibial Artery with Four or More Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
  • 047Q342 — Dilation of Left Anterior Tibial Artery with Drug-eluting Intraluminal Device, Sustained Release, Percutaneous Approach
  • 047Q352 — Dilation of Left Anterior Tibial Artery with Two Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
  • 047Q362 — Dilation of Left Anterior Tibial Artery with Three Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
  • 047Q372 — Dilation of Left Anterior Tibial Artery with Four or More Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
  • 047R342 — Dilation of Right Posterior Tibial Artery with Drug-eluting Intraluminal Device, Sustained Release, Percutaneous Approach
  • 047R352 — Dilation of Right Posterior Tibial Artery with Two Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
  • 047R362 — Dilation of Right Posterior Tibial Artery with Three Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
  • 047R372 — Dilation of Right Posterior Tibial Artery with Four or More Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
  • 047S342 — Dilation of Left Posterior Tibial Artery with Drug-eluting Intraluminal Device, Sustained Release, Percutaneous Approach
  • 047S352 — Dilation of Left Posterior Tibial Artery with Two Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
  • 047S362 — Dilation of Left Posterior Tibial Artery with Three Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
  • 047S372 — Dilation of Left Posterior Tibial Artery with Four or More Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
  • 047T342 — Dilation of Right Peroneal Artery with Drug-eluting Intraluminal Device, Sustained Release, Percutaneous Approach
  • 047T352 — Dilation of Right Peroneal Artery with Two Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
  • 047T362 — Dilation of Right Peroneal Artery with Three Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
  • 047T372 — Dilation of Right Peroneal Artery with Four or More Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
  • 047U342 — Dilation of Left Peroneal Artery with Drug-eluting Intraluminal Device, Sustained Release, Percutaneous Approach
  • 047U352 — Dilation of Left Peroneal Artery with Two Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
  • 047U362 — Dilation of Left Peroneal Artery with Three Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
  • 047U372 — Dilation of Left Peroneal Artery with Four or More Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
  • 07100Z3 — Bypass Head Lymphatic to Peripheral Vein, Open Approach
  • 07100Z4 — Bypass Head Lymphatic to Central Vein, Open Approach
  • 07100Z7 — Bypass Head Lymphatic to Lymphatic, Open Approach
  • 07100ZK — Bypass Head Lymphatic to Thoracic Duct, Open Approach
  • 07100ZL — Bypass Head Lymphatic to Cisterna Chyli, Open Approach
  • 07104Z3 — Bypass Head Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach
  • 07104Z4 — Bypass Head Lymphatic to Central Vein, Percutaneous Endoscopic Approach
  • 07104Z7 — Bypass Head Lymphatic to Lymphatic, Percutaneous Endoscopic Approach
  • 07104ZK — Bypass Head Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach
  • 07104ZL — Bypass Head Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach
  • 07110Z3 — Bypass Right Neck Lymphatic to Peripheral Vein, Open Approach
  • 07110Z4 — Bypass Right Neck Lymphatic to Central Vein, Open Approach
  • 07110Z7 — Bypass Right Neck Lymphatic to Lymphatic, Open Approach
  • 07110ZK — Bypass Right Neck Lymphatic to Thoracic Duct, Open Approach
  • 07110ZL — Bypass Right Neck Lymphatic to Cisterna Chyli, Open Approach
  • 07114Z3 — Bypass Right Neck Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach
  • 07114Z4 — Bypass Right Neck Lymphatic to Central Vein, Percutaneous Endoscopic Approach
  • 07114Z7 — Bypass Right Neck Lymphatic to Lymphatic, Percutaneous Endoscopic Approach
  • 07114ZK — Bypass Right Neck Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach
  • 07114ZL — Bypass Right Neck Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach
  • 07120Z3 — Bypass Left Neck Lymphatic to Peripheral Vein, Open Approach
  • 07120Z4 — Bypass Left Neck Lymphatic to Central Vein, Open Approach
  • 07120Z7 — Bypass Left Neck Lymphatic to Lymphatic, Open Approach
  • 07120ZK — Bypass Left Neck Lymphatic to Thoracic Duct, Open Approach
  • 07120ZL — Bypass Left Neck Lymphatic to Cisterna Chyli, Open Approach
  • 07124Z3 — Bypass Left Neck Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach
  • 07124Z4 — Bypass Left Neck Lymphatic to Central Vein, Percutaneous Endoscopic Approach
  • 07124Z7 — Bypass Left Neck Lymphatic to Lymphatic, Percutaneous Endoscopic Approach
  • 07124ZK — Bypass Left Neck Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach
  • 07124ZL — Bypass Left Neck Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach
  • 07130Z3 — Bypass Right Upper Extremity Lymphatic to Peripheral Vein, Open Approach
  • 07130Z4 — Bypass Right Upper Extremity Lymphatic to Central Vein, Open Approach
  • 07130Z7 — Bypass Right Upper Extremity Lymphatic to Lymphatic, Open Approach
  • 07130ZK — Bypass Right Upper Extremity Lymphatic to Thoracic Duct, Open Approach
  • 07130ZL — Bypass Right Upper Extremity Lymphatic to Cisterna Chyli, Open Approach
  • 07134Z3 — Bypass Right Upper Extremity Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach
  • 07134Z4 — Bypass Right Upper Extremity Lymphatic to Central Vein, Percutaneous Endoscopic Approach
  • 07134Z7 — Bypass Right Upper Extremity Lymphatic to Lymphatic, Percutaneous Endoscopic Approach
  • 07134ZK — Bypass Right Upper Extremity Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach
  • 07134ZL — Bypass Right Upper Extremity Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach
  • 07140Z3 — Bypass Left Upper Extremity Lymphatic to Peripheral Vein, Open Approach
  • 07140Z4 — Bypass Left Upper Extremity Lymphatic to Central Vein, Open Approach
  • 07140Z7 — Bypass Left Upper Extremity Lymphatic to Lymphatic, Open Approach
  • 07140ZK — Bypass Left Upper Extremity Lymphatic to Thoracic Duct, Open Approach
  • 07140ZL — Bypass Left Upper Extremity Lymphatic to Cisterna Chyli, Open Approach
  • 07144Z3 — Bypass Left Upper Extremity Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach
  • 07144Z4 — Bypass Left Upper Extremity Lymphatic to Central Vein, Percutaneous Endoscopic Approach
  • 07144Z7 — Bypass Left Upper Extremity Lymphatic to Lymphatic, Percutaneous Endoscopic Approach
  • 07144ZK — Bypass Left Upper Extremity Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach
  • 07144ZL — Bypass Left Upper Extremity Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach
  • 07150Z3 — Bypass Right Axillary Lymphatic to Peripheral Vein, Open Approach
  • 07150Z4 — Bypass Right Axillary Lymphatic to Central Vein, Open Approach
  • 07150Z7 — Bypass Right Axillary Lymphatic to Lymphatic, Open Approach
  • 07150ZK — Bypass Right Axillary Lymphatic to Thoracic Duct, Open Approach
  • 07150ZL — Bypass Right Axillary Lymphatic to Cisterna Chyli, Open Approach
  • 07154Z3 — Bypass Right Axillary Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach
  • 07154Z4 — Bypass Right Axillary Lymphatic to Central Vein, Percutaneous Endoscopic Approach
  • 07154Z7 — Bypass Right Axillary Lymphatic to Lymphatic, Percutaneous Endoscopic Approach
  • 07154ZK — Bypass Right Axillary Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach
  • 07154ZL — Bypass Right Axillary Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach
  • 07160Z3 — Bypass Left Axillary Lymphatic to Peripheral Vein, Open Approach
  • 07160Z4 — Bypass Left Axillary Lymphatic to Central Vein, Open Approach
  • 07160Z7 — Bypass Left Axillary Lymphatic to Lymphatic, Open Approach
  • 07160ZK — Bypass Left Axillary Lymphatic to Thoracic Duct, Open Approach
  • 07160ZL — Bypass Left Axillary Lymphatic to Cisterna Chyli, Open Approach
  • 07164Z3 — Bypass Left Axillary Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach
  • 07164Z4 — Bypass Left Axillary Lymphatic to Central Vein, Percutaneous Endoscopic Approach
  • 07164Z7 — Bypass Left Axillary Lymphatic to Lymphatic, Percutaneous Endoscopic Approach
  • 07164ZK — Bypass Left Axillary Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach
  • 07164ZL — Bypass Left Axillary Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach
  • 07170Z3 — Bypass Thorax Lymphatic to Peripheral Vein, Open Approach
  • 07170Z4 — Bypass Thorax Lymphatic to Central Vein, Open Approach
  • 07170Z7 — Bypass Thorax Lymphatic to Lymphatic, Open Approach
  • 07170ZK — Bypass Thorax Lymphatic to Thoracic Duct, Open Approach
  • 07170ZL — Bypass Thorax Lymphatic to Cisterna Chyli, Open Approach
  • 07174Z3 — Bypass Thorax Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach
  • 07174Z4 — Bypass Thorax Lymphatic to Central Vein, Percutaneous Endoscopic Approach
  • 07174Z7 — Bypass Thorax Lymphatic to Lymphatic, Percutaneous Endoscopic Approach
  • 07174ZK — Bypass Thorax Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach
  • 07174ZL — Bypass Thorax Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach
  • 07180Z3 — Bypass Right Internal Mammary Lymphatic to Peripheral Vein, Open Approach
  • 07180Z4 — Bypass Right Internal Mammary Lymphatic to Central Vein, Open Approach
  • 07180Z7 — Bypass Right Internal Mammary Lymphatic to Lymphatic, Open Approach
  • 07180ZK — Bypass Right Internal Mammary Lymphatic to Thoracic Duct, Open Approach
  • 07180ZL — Bypass Right Internal Mammary Lymphatic to Cisterna Chyli, Open Approach
  • 07184Z3 — Bypass Right Internal Mammary Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach
  • 07184Z4 — Bypass Right Internal Mammary Lymphatic to Central Vein, Percutaneous Endoscopic Approach
  • 07184Z7 — Bypass Right Internal Mammary Lymphatic to Lymphatic, Percutaneous Endoscopic Approach
  • 07184ZK — Bypass Right Internal Mammary Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach
  • 07184ZL — Bypass Right Internal Mammary Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach
  • 07190Z3 — Bypass Left Internal Mammary Lymphatic to Peripheral Vein, Open Approach
  • 07190Z4 — Bypass Left Internal Mammary Lymphatic to Central Vein, Open Approach
  • 07190Z7 — Bypass Left Internal Mammary Lymphatic to Lymphatic, Open Approach
  • 07190ZK — Bypass Left Internal Mammary Lymphatic to Thoracic Duct, Open Approach
  • 07190ZL — Bypass Left Internal Mammary Lymphatic to Cisterna Chyli, Open Approach
  • 07194Z3 — Bypass Left Internal Mammary Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach
  • 07194Z4 — Bypass Left Internal Mammary Lymphatic to Central Vein, Percutaneous Endoscopic Approach
  • 07194Z7 — Bypass Left Internal Mammary Lymphatic to Lymphatic, Percutaneous Endoscopic Approach
  • 07194ZK — Bypass Left Internal Mammary Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach
  • 07194ZL — Bypass Left Internal Mammary Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach
  • 071B0Z3 — Bypass Mesenteric Lymphatic to Peripheral Vein, Open Approach
  • 071B0Z4 — Bypass Mesenteric Lymphatic to Central Vein, Open Approach
  • 071B0Z7 — Bypass Mesenteric Lymphatic to Lymphatic, Open Approach
  • 071B0ZK — Bypass Mesenteric Lymphatic to Thoracic Duct, Open Approach
  • 071B0ZL — Bypass Mesenteric Lymphatic to Cisterna Chyli, Open Approach
  • 071B4Z3 — Bypass Mesenteric Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach
  • 071B4Z4 — Bypass Mesenteric Lymphatic to Central Vein, Percutaneous Endoscopic Approach
  • 071B4Z7 — Bypass Mesenteric Lymphatic to Lymphatic, Percutaneous Endoscopic Approach
  • 071B4ZK — Bypass Mesenteric Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach
  • 071B4ZL — Bypass Mesenteric Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach
  • 071C0Z3 — Bypass Pelvis Lymphatic to Peripheral Vein, Open Approach
  • 071C0Z4 — Bypass Pelvis Lymphatic to Central Vein, Open Approach
  • 071C0Z7 — Bypass Pelvis Lymphatic to Lymphatic, Open Approach
  • 071C0ZK — Bypass Pelvis Lymphatic to Thoracic Duct, Open Approach
  • 071C0ZL — Bypass Pelvis Lymphatic to Cisterna Chyli, Open Approach
  • 071C4Z3 — Bypass Pelvis Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach
  • 071C4Z4 — Bypass Pelvis Lymphatic to Central Vein, Percutaneous Endoscopic Approach
  • 071C4Z7 — Bypass Pelvis Lymphatic to Lymphatic, Percutaneous Endoscopic Approach
  • 071C4ZK — Bypass Pelvis Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach
  • 071C4ZL — Bypass Pelvis Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach
  • 071D0Z3 — Bypass Aortic Lymphatic to Peripheral Vein, Open Approach
  • 071D0Z4 — Bypass Aortic Lymphatic to Central Vein, Open Approach
  • 071D0Z7 — Bypass Aortic Lymphatic to Lymphatic, Open Approach
  • 071D0ZK — Bypass Aortic Lymphatic to Thoracic Duct, Open Approach
  • 071D0ZL — Bypass Aortic Lymphatic to Cisterna Chyli, Open Approach
  • 071D4Z3 — Bypass Aortic Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach
  • 071D4Z4 — Bypass Aortic Lymphatic to Central Vein, Percutaneous Endoscopic Approach
  • 071D4Z7 — Bypass Aortic Lymphatic to Lymphatic, Percutaneous Endoscopic Approach
  • 071D4ZK — Bypass Aortic Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach
  • 071D4ZL — Bypass Aortic Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach
  • 071F0Z3 — Bypass Right Lower Extremity Lymphatic to Peripheral Vein, Open Approach
  • 071F0Z4 — Bypass Right Lower Extremity Lymphatic to Central Vein, Open Approach
  • 071F0Z7 — Bypass Right Lower Extremity Lymphatic to Lymphatic, Open Approach
  • 071F0ZK — Bypass Right Lower Extremity Lymphatic to Thoracic Duct, Open Approach
  • 071F0ZL — Bypass Right Lower Extremity Lymphatic to Cisterna Chyli, Open Approach
  • 071F4Z3 — Bypass Right Lower Extremity Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach
  • 071F4Z4 — Bypass Right Lower Extremity Lymphatic to Central Vein, Percutaneous Endoscopic Approach
  • 071F4Z7 — Bypass Right Lower Extremity Lymphatic to Lymphatic, Percutaneous Endoscopic Approach
  • 071F4ZK — Bypass Right Lower Extremity Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach
  • 071F4ZL — Bypass Right Lower Extremity Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach
  • 071G0Z3 — Bypass Left Lower Extremity Lymphatic to Peripheral Vein, Open Approach
  • 071G0Z4 — Bypass Left Lower Extremity Lymphatic to Central Vein, Open Approach
  • 071G0Z7 — Bypass Left Lower Extremity Lymphatic to Lymphatic, Open Approach
  • 071G0ZK — Bypass Left Lower Extremity Lymphatic to Thoracic Duct, Open Approach
  • 071G0ZL — Bypass Left Lower Extremity Lymphatic to Cisterna Chyli, Open Approach
  • 071G4Z3 — Bypass Left Lower Extremity Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach
  • 071G4Z4 — Bypass Left Lower Extremity Lymphatic to Central Vein, Percutaneous Endoscopic Approach
  • 071G4Z7 — Bypass Left Lower Extremity Lymphatic to Lymphatic, Percutaneous Endoscopic Approach
  • 071G4ZK — Bypass Left Lower Extremity Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach
  • 071G4ZL — Bypass Left Lower Extremity Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach
  • 071H0Z3 — Bypass Right Inguinal Lymphatic to Peripheral Vein, Open Approach
  • 071H0Z4 — Bypass Right Inguinal Lymphatic to Central Vein, Open Approach
  • 071H0Z7 — Bypass Right Inguinal Lymphatic to Lymphatic, Open Approach
  • 071H0ZK — Bypass Right Inguinal Lymphatic to Thoracic Duct, Open Approach
  • 071H0ZL — Bypass Right Inguinal Lymphatic to Cisterna Chyli, Open Approach
  • 071H4Z3 — Bypass Right Inguinal Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach
  • 071H4Z4 — Bypass Right Inguinal Lymphatic to Central Vein, Percutaneous Endoscopic Approach
  • 071H4Z7 — Bypass Right Inguinal Lymphatic to Lymphatic, Percutaneous Endoscopic Approach
  • 071H4ZK — Bypass Right Inguinal Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach
  • 071H4ZL — Bypass Right Inguinal Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach
  • 071J0Z3 — Bypass Left Inguinal Lymphatic to Peripheral Vein, Open Approach
  • 071J0Z4 — Bypass Left Inguinal Lymphatic to Central Vein, Open Approach
  • 071J0Z7 — Bypass Left Inguinal Lymphatic to Lymphatic, Open Approach
  • 071J0ZK — Bypass Left Inguinal Lymphatic to Thoracic Duct, Open Approach
  • 071J0ZL — Bypass Left Inguinal Lymphatic to Cisterna Chyli, Open Approach
  • 071J4Z3 — Bypass Left Inguinal Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach
  • 071J4Z4 — Bypass Left Inguinal Lymphatic to Central Vein, Percutaneous Endoscopic Approach
  • 071J4Z7 — Bypass Left Inguinal Lymphatic to Lymphatic, Percutaneous Endoscopic Approach
  • 071J4ZK — Bypass Left Inguinal Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach
  • 071J4ZL — Bypass Left Inguinal Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach
  • 071K0Z3 — Bypass Thoracic Duct to Peripheral Vein, Open Approach
  • 071K0Z4 — Bypass Thoracic Duct to Central Vein, Open Approach
  • 071K0Z7 — Bypass Thoracic Duct to Lymphatic, Open Approach
  • 071K0ZK — Bypass Thoracic Duct to Thoracic Duct, Open Approach
  • 071K0ZL — Bypass Thoracic Duct to Cisterna Chyli, Open Approach
  • 071K4Z3 — Bypass Thoracic Duct to Peripheral Vein, Percutaneous Endoscopic Approach
  • 071K4Z4 — Bypass Thoracic Duct to Central Vein, Percutaneous Endoscopic Approach
  • 071K4Z7 — Bypass Thoracic Duct to Lymphatic, Percutaneous Endoscopic Approach
  • 071K4ZK — Bypass Thoracic Duct to Thoracic Duct, Percutaneous Endoscopic Approach
  • 071K4ZL — Bypass Thoracic Duct to Cisterna Chyli, Percutaneous Endoscopic Approach
  • 071L0Z3 — Bypass Cisterna Chyli to Peripheral Vein, Open Approach
  • 071L0Z4 — Bypass Cisterna Chyli to Central Vein, Open Approach
  • 071L0Z7 — Bypass Cisterna Chyli to Lymphatic, Open Approach
  • 071L0ZK — Bypass Cisterna Chyli to Thoracic Duct, Open Approach
  • 071L0ZL — Bypass Cisterna Chyli to Cisterna Chyli, Open Approach
  • 071L4Z3 — Bypass Cisterna Chyli to Peripheral Vein, Percutaneous Endoscopic Approach
  • 071L4Z4 — Bypass Cisterna Chyli to Central Vein, Percutaneous Endoscopic Approach
  • 071L4Z7 — Bypass Cisterna Chyli to Lymphatic, Percutaneous Endoscopic Approach
  • 071L4ZK — Bypass Cisterna Chyli to Thoracic Duct, Percutaneous Endoscopic Approach
  • 071L4ZL — Bypass Cisterna Chyli to Cisterna Chyli, Percutaneous Endoscopic Approach
  • 0FP480Z — Removal of Drainage Device from Gallbladder, Via Natural or Artificial Opening Endoscopic
  • 0FPG80Z — Removal of Drainage Device from Pancreas, Via Natural or Artificial Opening Endoscopic
  • 0FW480Z — Revision of Drainage Device in Gallbladder, Via Natural or Artificial Opening Endoscopic
  • 0FWG80Z — Revision of Drainage Device in Pancreas, Via Natural or Artificial Opening Endoscopic
  • 0HRT07B — Replacement of Right Breast using Lumbar Artery Perforator Flap, Open Approach
  • 0HRU07B — Replacement of Left Breast using Lumbar Artery Perforator Flap, Open Approach
  • 0HRV07B — Replacement of Bilateral Breast using Lumbar Artery Perforator Flap, Open Approach
  • 0NPB05Z — Removal of External Fixation Device from Nasal Bone, Open Approach
  • 0NPB35Z — Removal of External Fixation Device from Nasal Bone, Percutaneous Approach
  • 0NPB45Z — Removal of External Fixation Device from Nasal Bone, Percutaneous Endoscopic Approach
  • 0NPBX5Z — Removal of External Fixation Device from Nasal Bone, External Approach
  • 0NPW05Z — Removal of External Fixation Device from Facial Bone, Open Approach
  • 0NPW35Z — Removal of External Fixation Device from Facial Bone, Percutaneous Approach
  • 0NPW45Z — Removal of External Fixation Device from Facial Bone, Percutaneous Endoscopic Approach
  • 0NPWX5Z — Removal of External Fixation Device from Facial Bone, External Approach
  • 0NWB05Z — Revision of External Fixation Device in Nasal Bone, Open Approach
  • 0NWB35Z — Revision of External Fixation Device in Nasal Bone, Percutaneous Approach
  • 0NWB45Z — Revision of External Fixation Device in Nasal Bone, Percutaneous Endoscopic Approach
  • 0NWBX5Z — Revision of External Fixation Device in Nasal Bone, External Approach
  • 0NWW05Z — Revision of External Fixation Device in Facial Bone, Open Approach
  • 0NWW35Z — Revision of External Fixation Device in Facial Bone, Percutaneous Approach
  • 0NWW45Z — Revision of External Fixation Device in Facial Bone, Percutaneous Endoscopic Approach
  • 0NWWX5Z — Revision of External Fixation Device in Facial Bone, External Approach
  • 5A05A0L — Extracorporeal Peripheral Veno-venous Filtration, Intraoperative
  • 8E023FZ — Fiber Optic 3D Guided Procedure of Circulatory System, Percutaneous Approach
  • X05133A — Destruction of Renal Sympathetic Nerve(s) using Radiofrequency Ablation, Percutaneous Approach, New Technology Group 10
  • X27P3TA — Dilation of Right Anterior Tibial Artery with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach, New Technology Group 10
  • X27Q3TA — Dilation of Left Anterior Tibial Artery with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach, New Technology Group 10
  • X27R3TA — Dilation of Right Posterior Tibial Artery with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach, New Technology Group 10
  • X27S3TA — Dilation of Left Posterior Tibial Artery with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach, New Technology Group 10
  • X27T3TA — Dilation of Right Peroneal Artery with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach, New Technology Group 10
  • X27U3TA — Dilation of Left Peroneal Artery with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach, New Technology Group 10
  • X28F3VA — Division of Aortic Valve using Intraluminal Bioprosthetic Valve Leaflet Splitting Technology in Existing Valve, Percutaneous Approach, New Technology Group 10
  • X2R50WA — Replacement of Right Upper Extremity Artery using Bioengineered Human Acellular Vessel, Open Approach, New Technology Group 10
  • X2R60WA — Replacement of Left Upper Extremity Artery using Bioengineered Human Acellular Vessel, Open Approach, New Technology Group 10
  • X2R70WA — Replacement of Right Lower Extremity Artery using Bioengineered Human Acellular Vessel, Open Approach, New Technology Group 10
  • X2R80WA — Replacement of Left Lower Extremity Artery using Bioengineered Human Acellular Vessel, Open Approach, New Technology Group 10
  • X2RJ3RA — Replacement of Tricuspid Valve with Multi-plane Flex Technology Bioprosthetic Valve, Percutaneous Approach, New Technology Group 10
  • X2VE3SA — Restriction of Descending Thoracic Aorta and Abdominal Aorta using Branched Intraluminal Device, Manufactured Integrated System, Four or More Arteries, Percutaneous Approach, New Technology Group 10
  • XHR0XGA — Replacement of Head and Neck Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10
  • XHR1XGA — Replacement of Chest Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10
  • XHR2XGA — Replacement of Abdomen Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10
  • XHR3XGA — Replacement of Back Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10
  • XHR4XGA — Replacement of Right Upper Extremity Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10
  • XHR5XGA — Replacement of Left Upper Extremity Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10
  • XHR6XGA — Replacement of Right Lower Extremity Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10
  • XHR7XGA — Replacement of Left Lower Extremity Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10
  • XRGA0EA — Fusion of Thoracolumbar Vertebral Joint using Facet Joint Fusion Device, Paired Titanium Cages, Open Approach, New Technology Group 10
  • XRGB0EA — Fusion of Lumbar Vertebral Joint using Facet Joint Fusion Device, Paired Titanium Cages, Open Approach, New Technology Group 10
  • XRGC0EA — Fusion of 2 or more Lumbar Vertebral Joints using Facet Joint Fusion Device, Paired Titanium Cages, Open Approach, New Technology Group 10
  • XRGD0EA — Fusion of Lumbosacral Joint using Facet Joint Fusion Device, Paired Titanium Cages, Open Approach, New Technology Group 10
  • XRGJ0CA — Fusion of Right Ankle Joint using Gyroid-Sheet Lattice Design Internal Fixation Device, Open Approach, New Technology Group 10
  • XRGK0CA — Fusion of Left Ankle Joint using Gyroid-Sheet Lattice Design Internal Fixation Device, Open Approach, New Technology Group 10
  • XRGL0CA — Fusion of Right Tarsal Joint using Gyroid-Sheet Lattice Design Internal Fixation Device, Open Approach, New Technology Group 10
  • XRGM0CA — Fusion of Left Tarsal Joint using Gyroid-Sheet Lattice Design Internal Fixation Device, Open Approach, New Technology Group 10
  • XRH60FA — Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into Thoracic Vertebral Joint, Open Approach, New Technology Group 10
  • XRH63FA — Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into Thoracic Vertebral Joint, Percutaneous Approach, New Technology Group 10
  • XRH64FA — Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into Thoracic Vertebral Joint, Percutaneous Endoscopic Approach, New Technology Group 10
  • XRH70FA — Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into 2 to 7 Thoracic Vertebral Joints, Open Approach, New Technology Group 10
  • XRH73FA — Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into 2 to 7 Thoracic Vertebral Joints, Percutaneous Approach, New Technology Group 10
  • XRH74FA — Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into 2 to 7 Thoracic Vertebral Joints, Percutaneous Endoscopic Approach, New Technology Group 10
  • XRH80FA — Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into 8 or more Thoracic Vertebral Joints, Open Approach, New Technology Group 10
  • XRH83FA — Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into 8 or more Thoracic Vertebral Joints, Percutaneous Approach, New Technology Group 10
  • XRH84FA — Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into 8 or more Thoracic Vertebral Joints, Percutaneous Endoscopic Approach, New Technology Group 10
  • XRHA0FA — Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into Thoracolumbar Vertebral Joint, Open Approach, New Technology Group 10
  • XRHA3FA — Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into Thoracolumbar Vertebral Joint, Percutaneous Approach, New Technology Group 10
  • XRHA4FA — Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into Thoracolumbar Vertebral Joint, Percutaneous Endoscopic Approach, New Technology Group 10
  • XRHB0FA — Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into Lumbar Vertebral Joint, Open Approach, New Technology Group 10
  • XRHB3FA — Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into Lumbar Vertebral Joint, Percutaneous Approach, New Technology Group 10
  • XRHB4FA — Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into Lumbar Vertebral Joint, Percutaneous Endoscopic Approach, New Technology Group 10
  • XRHC0FA — Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into 2 or more Lumbar Vertebral Joints, Open Approach, New Technology Group 10
  • XRHC3FA — Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into 2 or more Lumbar Vertebral Joints, Percutaneous Approach, New Technology Group 10
  • XRHC4FA — Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into 2 or more Lumbar Vertebral Joints, Percutaneous Endoscopic Approach, New Technology Group 10
  • XRHD0FA — Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into Lumbosacral Joint, Open Approach, New Technology Group 10
  • XRHD3FA — Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into Lumbosacral Joint, Percutaneous Approach, New Technology Group 10
  • XRHD4FA — Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into Lumbosacral Joint, Percutaneous Endoscopic Approach, New Technology Group 10
  • XW0136A — Introduction of Dasiglucagon into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 10
  • XW0333A — Introduction of Bentracimab, Ticagrelor Reversal Agent into Peripheral Vein, Percutaneous Approach, New Technology Group 10
  • XW0334A — Introduction of Cefepime-taniborbactam Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 10
  • XW0335A — Introduction of Ceftobiprole Medocaril Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 10
  • XW0338A — Introduction of Obecabtagene Autoleucel into Peripheral Vein, Percutaneous Approach, New Technology Group 10
  • XW0339A — Introduction of Odronextamab Antineoplastic into Peripheral Vein, Percutaneous Approach, New Technology Group 10
  • XW033BA — Introduction of Orca-T Allogeneic T-cell Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 10
  • XW033CA — Introduction of Zanidatamab Antineoplastic into Peripheral Vein, Percutaneous Approach, New Technology Group 10
  • XW033DA — Introduction of Donislecel-jujn Allogeneic Pancreatic Islet Cellular Suspension into Peripheral Vein, Percutaneous Approach, New Technology Group 10
  • XW033FA — Introduction of Non-Chimeric Antigen Receptor T-cell Immune Effector Cell Therapy into Peripheral Vein, Percutaneous Approach, New Technology Group 10
  • XW0433A — Introduction of Bentracimab, Ticagrelor Reversal Agent into Central Vein, Percutaneous Approach, New Technology Group 10
  • XW0434A — Introduction of Cefepime-taniborbactam Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 10
  • XW0435A — Introduction of Ceftobiprole Medocaril Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 10
  • XW0438A — Introduction of Obecabtagene Autoleucel into Central Vein, Percutaneous Approach, New Technology Group 10
  • XW0439A — Introduction of Odronextamab Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 10
  • XW043BA — Introduction of Orca-T Allogeneic T-cell Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 10
  • XW043CA — Introduction of Zanidatamab Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 10
  • XW043FA — Introduction of Non-Chimeric Antigen Receptor T-cell Immune Effector Cell Therapy into Central Vein, Percutaneous Approach, New Technology Group 10
  • XW0J3HA — Introduction of Paclitaxel-Coated Balloon Technology, One Balloon into Coronary Artery, One Artery, Percutaneous Approach, New Technology Group 10
  • XW0J3JA — Introduction of Paclitaxel-Coated Balloon Technology, Two Balloons into Coronary Artery, One Artery, Percutaneous Approach, New Technology Group 10
  • XW0J3KA — Introduction of Paclitaxel-Coated Balloon Technology, Three Balloons into Coronary Artery, One Artery, Percutaneous Approach, New Technology Group 10
  • XW0J3LA — Introduction of Paclitaxel-Coated Balloon Technology, Four or More Balloons into Coronary Artery, One Artery, Percutaneous Approach, New Technology Group 10
  • XW0K3HA — Introduction of Paclitaxel-Coated Balloon Technology, One Balloon into Coronary Artery, Two Arteries, Percutaneous Approach, New Technology Group 10
  • XW0K3JA — Introduction of Paclitaxel-Coated Balloon Technology, Two Balloons into Coronary Artery, Two Arteries, Percutaneous Approach, New Technology Group 10
  • XW0K3KA — Introduction of Paclitaxel-Coated Balloon Technology, Three Balloons into Coronary Artery, Two Arteries, Percutaneous Approach, New Technology Group 10
  • XW0K3LA — Introduction of Paclitaxel-Coated Balloon Technology, Four or More Balloons into Coronary Artery, Two Arteries, Percutaneous Approach, New Technology Group 10
  • XW0L3HA — Introduction of Paclitaxel-Coated Balloon Technology, One Balloon into Coronary Artery, Three Arteries, Percutaneous Approach, New Technology Group 10
  • XW0L3JA — Introduction of Paclitaxel-Coated Balloon Technology, Two Balloons into Coronary Artery, Three Arteries, Percutaneous Approach, New Technology Group 10
  • XW0L3KA — Introduction of Paclitaxel-Coated Balloon Technology, Three Balloons into Coronary Artery, Three Arteries, Percutaneous Approach, New Technology Group 10
  • XW0L3LA — Introduction of Paclitaxel-Coated Balloon Technology, Four or More Balloons into Coronary Artery, Three Arteries, Percutaneous Approach, New Technology Group 10
  • XW0M3HA — Introduction of Paclitaxel-Coated Balloon Technology, One Balloon into Coronary Artery, Four or More Arteries, Percutaneous Approach, New Technology Group 10
  • XW0M3JA — Introduction of Paclitaxel-Coated Balloon Technology, Two Balloons into Coronary Artery, Four or More Arteries, Percutaneous Approach, New Technology Group 10
  • XW0M3KA — Introduction of Paclitaxel-Coated Balloon Technology, Three Balloons into Coronary Artery, Four or More Arteries, Percutaneous Approach, New Technology Group 10
  • XW0M3LA — Introduction of Paclitaxel-Coated Balloon Technology, Four or More Balloons into Coronary Artery, Four or More Arteries, Percutaneous Approach, New Technology Group 10
  • XW0U0GA — Introduction of Vancomycin Hydrochloride and Tobramycin Sulfate Anti-Infective, Temporary Irrigation Spacer System into Joints, Open Approach, New Technology Group 10
  • XW0V3WA — Introduction of AGN1 Bone Void Filler into Bones, Percutaneous Approach, New Technology Group 10
  • XW1337A — Transfusion of Marnetegragene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 10
  • XW1437A — Transfusion of Marnetegragene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 10
  • XX25X0A — Monitoring of Blood Flow, Adhesive Ultrasound Patch Technology, New Technology Group 10
  • XXA536A — Circulatory Filtration, Blood Pathogens, Percutaneous Approach, New Technology Group 10
  • XXE0X1A — Measurement of Intracranial Cerebrospinal Fluid Flow, Computer-aided Triage and Notification, New Technology Group 10
  • XXE5X2A — Measurement of Infection, Phenotypic Fully Automated Rapid Susceptibility Technology with Controlled Inoculum, New Technology Group 10
  • XXE5X4A — Measurement of Infection, Positive Blood Culture Small Molecule Sensor Array Technology, New Technology Group 10

Removed from the code set (61)

  • X27H385 — Dilation of Right Femoral Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5
  • X27H395 — Dilation of Right Femoral Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27H3B5 — Dilation of Right Femoral Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27H3C5 — Dilation of Right Femoral Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27J385 — Dilation of Left Femoral Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5
  • X27J395 — Dilation of Left Femoral Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27J3B5 — Dilation of Left Femoral Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27J3C5 — Dilation of Left Femoral Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27K385 — Dilation of Proximal Right Popliteal Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5
  • X27K395 — Dilation of Proximal Right Popliteal Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27K3B5 — Dilation of Proximal Right Popliteal Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27K3C5 — Dilation of Proximal Right Popliteal Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27L385 — Dilation of Proximal Left Popliteal Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5
  • X27L395 — Dilation of Proximal Left Popliteal Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27L3B5 — Dilation of Proximal Left Popliteal Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27L3C5 — Dilation of Proximal Left Popliteal Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27M385 — Dilation of Distal Right Popliteal Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5
  • X27M395 — Dilation of Distal Right Popliteal Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27M3B5 — Dilation of Distal Right Popliteal Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27M3C5 — Dilation of Distal Right Popliteal Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27N385 — Dilation of Distal Left Popliteal Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5
  • X27N395 — Dilation of Distal Left Popliteal Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27N3B5 — Dilation of Distal Left Popliteal Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27N3C5 — Dilation of Distal Left Popliteal Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27P385 — Dilation of Right Anterior Tibial Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5
  • X27P395 — Dilation of Right Anterior Tibial Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27P3B5 — Dilation of Right Anterior Tibial Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27P3C5 — Dilation of Right Anterior Tibial Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27Q385 — Dilation of Left Anterior Tibial Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5
  • X27Q395 — Dilation of Left Anterior Tibial Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27Q3B5 — Dilation of Left Anterior Tibial Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27Q3C5 — Dilation of Left Anterior Tibial Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27R385 — Dilation of Right Posterior Tibial Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5
  • X27R395 — Dilation of Right Posterior Tibial Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27R3B5 — Dilation of Right Posterior Tibial Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27R3C5 — Dilation of Right Posterior Tibial Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27S385 — Dilation of Left Posterior Tibial Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5
  • X27S395 — Dilation of Left Posterior Tibial Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27S3B5 — Dilation of Left Posterior Tibial Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27S3C5 — Dilation of Left Posterior Tibial Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27T385 — Dilation of Right Peroneal Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5
  • X27T395 — Dilation of Right Peroneal Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27T3B5 — Dilation of Right Peroneal Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27T3C5 — Dilation of Right Peroneal Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27U385 — Dilation of Left Peroneal Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5
  • X27U395 — Dilation of Left Peroneal Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27U3B5 — Dilation of Left Peroneal Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27U3C5 — Dilation of Left Peroneal Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • XW033K5 — Introduction of Fosfomycin Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 5
  • XW033N5 — Introduction of Meropenem-vaborbactam Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 5
  • XW033U5 — Introduction of Imipenem-cilastatin-relebactam Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 5
  • XW043K5 — Introduction of Fosfomycin Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 5
  • XW043N5 — Introduction of Meropenem-vaborbactam Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 5
  • XW043U5 — Introduction of Imipenem-cilastatin-relebactam Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 5
  • XW097M5 — Introduction of Esketamine Hydrochloride into Nose, Via Natural or Artificial Opening, New Technology Group 5
  • XW0DXJ5 — Introduction of Apalutamide Antineoplastic into Mouth and Pharynx, External Approach, New Technology Group 5
  • XW0DXL5 — Introduction of Erdafitinib Antineoplastic into Mouth and Pharynx, External Approach, New Technology Group 5
  • XW0DXR5 — Introduction of Venetoclax Antineoplastic into Mouth and Pharynx, External Approach, New Technology Group 5
  • XW0DXT5 — Introduction of Ruxolitinib into Mouth and Pharynx, External Approach, New Technology Group 5
  • XW0DXV5 — Introduction of Gilteritinib Antineoplastic into Mouth and Pharynx, External Approach, New Technology Group 5
  • XXE5XM5 — Measurement of Infection, Whole Blood Nucleic Acid-base Microbial Detection, New Technology Group 5

Sources

Official source data

Publisher
Centers for Medicare & Medicaid Services (CMS) and the National Center for Health Statistics (CDC/NCHS)
Release
ICD-10-PCS FY2025
Source file
2025-icd-10-pcs-codes-file.zip
File checksum (SHA-256)
8fd50f47f8927728e3a819c22403502a28dc4e996b7d907e3259c45bd418f99c
Data type
Public domain code descriptions and tabular instructions. No licensed content.

MedCoder-derived analysis

Change detection
Every addition, deletion, description revision, billable-status change and tabular-instruction change on this page is computed by diffing the two code-description files above, line by line.
Editorial analysis
The grouping of changes into themes, the successor determinations and the coder-impact notes are written by MedCoder against those files. They are not CMS statements.
Independence
MedCoder is an independent coding reference built on public federal data. It is not affiliated with, endorsed by or certified by CMS, and it is not an official CMS coding tool.

Continue

All releases in the Change Ledger

Cite this page

Reference this page in a research guide, syllabus or article. The release is included because code content changes each year.

MedCoder.ai. "ICD-10-PCS FY2025 code changes." ICD-10-PCS FY2025. https://medcoder.ai/updates/icd10pcs/icd10pcs-fy2025